[go: up one dir, main page]

CR6613A - CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE - Google Patents

CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE

Info

Publication number
CR6613A
CR6613A CR6613A CR6613A CR6613A CR 6613 A CR6613 A CR 6613A CR 6613 A CR6613 A CR 6613A CR 6613 A CR6613 A CR 6613A CR 6613 A CR6613 A CR 6613A
Authority
CR
Costa Rica
Prior art keywords
expression
adsss
genesis
live
changing
Prior art date
Application number
CR6613A
Other languages
Spanish (es)
Inventor
A Conrad Charles
Chen Yin
Original Assignee
Cytogenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytogenix Inc filed Critical Cytogenix Inc
Publication of CR6613A publication Critical patent/CR6613A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un metodo para alterar la expresion de una secuencia de acido nucleico objetivo en una celula objetivo mediante la produccion de ADNc de una sola cadena (ADNC-ss) en la celula objetivo in vivo.A method to alter the expression of a target nucleic acid sequence in a target cell by producing single-stranded cDNA (cDNA-ss) in the target cell in vivo.

CR6613A 1999-10-04 2002-04-03 CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE CR6613A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41156899A 1999-10-04 1999-10-04
US51470700A 2000-02-28 2000-02-28

Publications (1)

Publication Number Publication Date
CR6613A true CR6613A (en) 2004-04-21

Family

ID=27021437

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6613A CR6613A (en) 1999-10-04 2002-04-03 CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE

Country Status (11)

Country Link
EP (1) EP1222259A1 (en)
JP (1) JP2003511025A (en)
KR (1) KR20020059608A (en)
CN (1) CN1276083C (en)
AU (1) AU7855300A (en)
BR (1) BR0014814A (en)
CA (1) CA2386246A1 (en)
CR (1) CR6613A (en)
IL (1) IL148946A0 (en)
MX (1) MXPA02003422A (en)
WO (1) WO2001025419A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419964B2 (en) 1999-09-16 2008-09-02 Cytogenix, Inc. Treatment of HSV-related pathologies using ssDNA
ES2300375T3 (en) 2000-10-23 2008-06-16 Gen-Probe Incorporated COMPOSITIONS AND METHODS FOR THE DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS 2 (HIV-2).
MXPA04005747A (en) * 2001-12-14 2005-07-05 Univ Yale Intracellular generation of single-stranded dna.
US20050020526A1 (en) * 2003-06-03 2005-01-27 Cytogenix, Inc. Oligodeoxynucleotide intervention for prevention and treatment of sepsis
EP1802754A2 (en) * 2004-09-28 2007-07-04 CytoGenix, Inc. Single-stranded antimicrobial oligonucleotides and uses thereof
US8658608B2 (en) 2005-11-23 2014-02-25 Yale University Modified triple-helix forming oligonucleotides for targeted mutagenesis
CN102154269B (en) * 2011-01-06 2012-05-23 湖南农业大学 Rapid construction method of tandem repeat sequence based on PCR and special primer pair and its application
US11136597B2 (en) 2016-02-16 2021-10-05 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
CN108396043A (en) * 2017-02-06 2018-08-14 中国科学院上海应用物理研究所 A kind of preparation method and applications of the ends 5` phosphorylation single stranded DNA
JP7481755B2 (en) * 2018-11-02 2024-05-13 ナイキジェン，リミテッド Recombinant parvovirus vectors and methods for making and using same
GB201913898D0 (en) * 2019-09-26 2019-11-13 Lightbio Ltd Nucleic acid construct

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022114A1 (en) * 1998-10-09 2000-04-20 Ingene, Inc. PRODUCTION OF ssDNA $i(IN VIVO)
EP1117776A1 (en) * 1998-10-09 2001-07-25 Ingene, Inc. ENZYMATIC SYNTHESIS OF ssDNA

Also Published As

Publication number Publication date
EP1222259A1 (en) 2002-07-17
BR0014814A (en) 2002-09-17
KR20020059608A (en) 2002-07-13
WO2001025419A1 (en) 2001-04-12
AU7855300A (en) 2001-05-10
CN1276083C (en) 2006-09-20
JP2003511025A (en) 2003-03-25
MXPA02003422A (en) 2004-09-10
IL148946A0 (en) 2002-09-12
CN1399679A (en) 2003-02-26
CA2386246A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
ES2597953T3 (en) Oligoribonucleotide to inhibit the expression of a predetermined gene
AR031480A1 (en) 3-HYDROXIPROPIONIC ACID AND OTHER ORGANIC COMPOUNDS
CR6613A (en) CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE
CY1106821T1 (en) METHOD FOR CULTIVATING CARTILAGE SUBSTITUTE AND BIOLOGICAL UTERUS PRODUCED ACCORDING TO THE METHOD
MX9703063A (en) ESTER AND BORONIC ACID COMPOUNDS, THEIR SYNTHESIS AND USES.
ES2182897T3 (en) REGULATION BY PROTEASOME OF THE ACTIVITY OF NF-KAPPA-B.
AR027600A1 (en) POLYPEPTIDES THAT HAVE ALFA-AMYLASE ALKALINE ACTIVITY AND THE NUCLEIC ACIDS THAT CODE IT
BR9612258B1 (en) interleukin-1beta converting enzyme inhibitors as well as pharmaceutical composition.
ES2175753T3 (en) BIOSYNTHETIC GRAFT AND METHOD FOR PRODUCTION.
EP2816117A3 (en) Collagen producing plants and methods of generating and using same
DK1399590T3 (en) Happier mapping
DE60036537D1 (en) COMPOSITIONS FOR GENETHERAPY OF DIABETES
SV2005002082A (en) "PROLINA CCI-779, PRODUCTION AND USES OF THE SAME, AND ENZYMATIC SYNTHESIS OF TWO STAGES OF PROLINA CCI-779 AND CCI-779" REF. AM-101578SALVO
BR0116220A (en) Methods for the production of multimeric proteins and related compositions
BR0212227B1 (en) Fruit thinning agent and processes as well as their employment
BR9813099A (en) Positive-negative selection in homologous recombination
UA94613C2 (en) Modified enzyme dmo and transgenic plant, producing it
NO20020949L (en) Fatty acid desaturation gene from plants
AR069074A1 (en) MODIFICATION OF LIGNIN BIOSYNTHESIS BY SUPPRESSION WITH NUCLEIC ACID SENSE
WO2002032211A3 (en) Method of harvesting sugarcane
BRPI0416637A (en) method for producing an aqueous copper ethanolamine solution and a copper monoethanolamine solution
DE60117566D1 (en) INCREASED PREPARATION OF 2-KETO-L-GULONIC ACID
AR014528A1 (en) DNA THAT INCLUDES A SEQUENCE OF NUCLEOTIDES THAT CAN BE TRANSLATED TO A PROTEIN WITH ACTIVITY OF INVERTASE, PROTEIN DERIVED FROM DNA THAT HAS ACTIVITY OF INVERTASE BUT THAT LACKS OF BETA-FRUCTOFURANOSIDASE ACTIVITY; METHOD TO PRODUCE DNA AND SUCH METHOD WHERE DNA IS PRODUCED BY A
AR077315A2 (en) PLANTS WITH MODIFIED GROWTH CHARACTERISTICS AND METHOD TO OBTAIN THE SAME
AU2003285610A1 (en) Method to improve the information distribution in a communication network

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)